Sansone Randy A, Sansone Lori A
R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, OH, and Director of Psychiatry Education at Kettering Medical Center in Kettering, OH. L. Sansone is a civilian family medicine physician and Medical Director of the Family Health Clinic at Wright-Patterson Air Force Base Medical Center in WPAFB, OH. The views and opinions expressed in this article are those of the authors and do not reflect the official policy or position of the United States Air Force, Department of Defense, or United States Government.
Innov Clin Neurosci. 2014 Jul;11(7-8):50-4.
Acute marijuana use is classically associated with snacking behavior (colloquially referred to as "the munchies"). In support of these acute appetite-enhancing effects, several authorities report that marijuana may increase body mass index in patients suffering from human immunodeficiency virus and cancer. However, for these medical conditions, while appetite may be stimulated, some studies indicate that weight gain is not always clinically meaningful. In addition, in a study of cancer patients in which weight gain did occur, it was less than the comparator drug (megestrol). However, data generally suggest that acute marijuana use stimulates appetite, and that marijuana use may stimulate appetite in low-weight individuals. As for large epidemiological studies in the general population, findings consistently indicate that users of marijuana tend to have lower body mass indices than nonusers. While paradoxical and somewhat perplexing, these findings may be explained by various study confounds, such as potential differences between acute versus chronic marijuana use; the tendency for marijuana use to be associated with other types of drug use; and/or the possible competition between food and drugs for the same reward sites in the brain. Likewise, perhaps the effects of marijuana are a function of initial weight status-i.e., maybe marijuana is a metabolic regulatory substance that increases body weight in low-weight individuals but not in normal-weight or overweight individuals. Only further research will clarify the complex relationships between marijuana and body weight.
急性使用大麻通常与吃零食行为相关(通俗地称为“贪吃”)。为支持这些急性增强食欲的作用,一些权威机构报告称,大麻可能会使感染人类免疫缺陷病毒和患癌症的患者体重指数增加。然而,对于这些病症,虽然食欲可能会受到刺激,但一些研究表明体重增加在临床上并不总是有意义的。此外,在一项针对确实出现体重增加的癌症患者的研究中,体重增加幅度小于对照药物(甲地孕酮)。然而,总体数据表明,急性使用大麻会刺激食欲,而且大麻使用可能会刺激体重过轻个体的食欲。至于针对普通人群的大型流行病学研究,结果一致表明,大麻使用者的体重指数往往低于非使用者。虽然这些发现看似矛盾且有些令人困惑,但可能可以通过各种研究混杂因素来解释,比如急性与慢性大麻使用之间的潜在差异;大麻使用与其他类型药物使用相关的倾向;和/或食物与药物在大脑中相同奖励位点的可能竞争。同样,也许大麻的作用取决于初始体重状况——也就是说,也许大麻是一种代谢调节物质,能使体重过轻的个体体重增加,但对正常体重或超重个体则不然。只有进一步的研究才能阐明大麻与体重之间的复杂关系。